Evidence map›Paper›PMID 33460648›Full record

ArticleThe Journal of biological chemistry

Interaction of RIPK1 and A20 modulates MAPK signaling in murine acetaminophen toxicity.

Andrea Iorga, Katherine Donovan, Layla Shojaie, Heather Johnson, Janet Kwok, Jo Suda, Brian T Lee, Mariam Aghajan, Ling Shao, Zhang-Xu Liu and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Andrea IorgaDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; USC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Katherine DonovanUSC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Layla ShojaieUSC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Heather JohnsonDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; USC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Janet KwokDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Jo SudaUSC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; Cedar Sinai Medical Center, Los Angeles, California, USA.
Brian T LeeDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Mariam AghajanIONIS Pharmaceutical, Carlsbad, California, USA.
Ling ShaoDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; USC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Zhang-Xu LiuDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; USC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Lily DaraDivision of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California, USA; USC Research Center for Liver Disease, Keck School of Medicine of University of Southern California, Los Angeles, California, USA. Electronic address: lily.dara@usc.edu.
University of Southern California · USIonis Pharmaceuticals (United States) · US

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KANEL, GARY · 1995 to 2020
$21.8M
Role of RIPK1 and RIPK3 in liver injury.K08DK109141 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI DARA, LILY · 2016 to 2021
$925k
NIDDK NIH HHS K08 DK109141NIDDK NIH HHS P30 DK048522
6 · The paper itself

Abstract

Acetaminophen (APAP)-induced liver necrosis is a form of regulated cell death (RCD) in which APAP activates the mitogen-activated protein kinases (MAPKs) and specifically the c-Jun-N-terminal kinase (JNK) pathway, leading to necrotic cell death. Previously, we have shown that receptor interacting protein kinase-1 (RIPK1) knockdown is also protective against APAP RCD upstream of JNK. However, whether the kinase or platform function of RIPK1 is involved in APAP RCD is not known. To answer this question, we used genetic mouse models of targeted hepatocyte RIPK1 knockout (RIPK1

Indexed as

AcetaminophenAnimalsApoptosisChemical and Drug Induced Liver InjuryGene Expression RegulationHepatocytesLiverMaleMAP Kinase Kinase 4MAP Kinase Kinase Kinase 5MAP Kinase Signaling SystemMiceMice, TransgenicProtein BindingReceptor-Interacting Protein Serine-Threonine KinasesSeverity of Illness IndexAcetaminophenMap3k5 protein, mouseMAP Kinase Kinase 4MAP Kinase Kinase Kinase 5Receptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseTnfaip3 protein, mouseTumor Necrosis Factor alpha-Induced Protein 3cell deathdrug actiondrug induced liver injuryhepatotoxicitynecroptosisnecrosisreceptor interacting proteinRIPK1RIPK3TNFAIP3

Identifiers

PMID33460648
PMCPMC7948960
OpenAlexW3124666925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.